
Guidance document
This is guidance for manufacturers and sponsors on regulatory amendments defining shoulder, hip and knee joint replacement medical devices and ancillary medical devices.
These amendments came into effect on 20 April 2015, to clarify the appropriate classification for various medical devices supplied and used in shoulder, hip and knee joint replacements.
This guidance is provided in three sections:
Guidance document
Definitions have been included in the dictionary of the Therapeutic Goods (Medical Devices) Regulations 2002 for:
Joint replacement medical device means an implantable medical device:
Ancillary medical device means an implantable medical device that:
Hip joint means the ball and socket formed by the reception of the head of the femur into the cup-shaped cavity of the acetabulum.
Knee joint means the joint consisting of:
Shoulder joint means the ball-and-socket formed by the reception of the head of the humerus onto the glenoid cavity of the scapula.
Guidance document
The following section explains how the definitions operate in practice, including examples, for devices which:
Under paragraph (b)(i) of the joint replacement definition, the articulating surface of joints would be a Class III medical device. It includes devices that replace:
Examples include:

Under paragraph (b)(ii) of the joint replacement definition, devices which provide primary fixation of the joint replacement to the patient's bone would be a Class III medical device.
Examples include:

* If femoral or tibial knee stems are intended by the manufacturer to provide primary fixation to the bone they are to be classified as a Class III medical device. However, if these stems are intended by the manufacturer to be used where the individual requirements of the patient make it appropriate to do so, the device is not to be classified as a Class III medical device.
Under paragraph (b)(iii) of the joint replacement definition devices that connect directly or indirectly with the articulating surface and/or primary fixation and operates as an intrinsic element of the joint replacement would be a Class III medical device.
Examples include:

Devices that are intrinsic elements of the joint replacement may be directly or indirectly connected to the articulating surface and/or primary fixation. The example to the right shows a hip joint replacement:
The joint replacement definition specifically excludes ancillary devices. While ancillary devices may be required to enable the shoulder, hip or knee joint replacement medical device to operate as intended by the manufacturer, they do not replace the articulating surface of the joint, provide primary fixation or operate as an intrinsic element of the joint replacement and are therefore not classified as Class III medical devices.
Ancillary medical devices may provide additional stability either alone or together with other implantable medical devices, or provide bone substitution or additional fixation to assist in the implantation of the joint replacement where the individual requirements of a patient make it appropriate to do so. Screws, plates and wedges are specifically cited as ancillary devices.
Examples include:

* If femoral or tibial knee stems are intended by the manufacturer to provide primary fixation to the bone they are to be classified as a Class III medical device. However, if these stems are intended by the manufacturer to be used where the individual requirements of the patient make it appropriate to do so, the device is not to be classified as a Class III medical device.
Guidance document
This section provides background on the reclassification of joint replacements and how the need for these definitions arose:
To obtain greater assurance in the safety and performance of shoulder, hip and knee joint replacement medical devices, the European Commission issued Directive 2005/50/EC (pdf,40kb). This amended the classification of the implants from Class IIb to Class III medical devices. The European Commission released further guidance in January 2007 to clarify the intention of this classification rule:
On 1 July 2012, TGA amended the Therapeutic Goods (Medical Devices) Regulations 2002 (the Regulations) to align the classification of these devices in Australia with European Union arrangements, and to provide for a parallel level of rigour of premarket assessment of these joint replacement medical devices.
The TGA provided a two year transition period for sponsors of existing Class IIb Australian Register of Therapeutic Goods (ARTG) entries to apply to up-classify their devices. In April 2014 this transition period was extended by 12 months, from 30 June 2014 until 30 June 2015.
As the reclassification transition period progressed it became apparent that there were differences in interpretation of the classification rules within the Europe Union. Many manufacturers reply on European certification to support market entry in Australia. Given this it was agreed greater clarity was needed on which medical devices are joint replacements and so classified as Class lll medical devices under Australian regulations, and which devices act as ancillary devices to the joint replacement and are Class llb medical devices.
The transition period was extended in part to allow development of a definition of shoulder, hip and knee joint replacement medical devices and ancillary medical devices.